Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

IXICO Plc chief hugely excited by ‘really big growth opportunities’

Monday, November 21, 2016 7:59
% of readers think this story is Fact. Add your two cents.

(Before It's News)

IXICO chief executive Derek Hill caught up with Proactive to discuss the company’s full year results and new partnerships.

Hill tells Proactive: We’re very focused on the brain. Neurodegenerative diseases have been our longer term focus – the perhaps best known one of those – Alzheimer’s Disease which is the main cause of dementia.”

”Traditionally IXICO has, for the last 12 years, been working with pharmaceutical companies supporting them in developing drugs, particularly for neurodegenerative diseases … but recently we’ve also got some of our technology crossing over from the world of developing drugs into being used alongside drugs in the clinics”.

”We’re using technology that we have for many years been applying to support pharmaceutical companies developing drugs. We’re now using that to help make those drugs safer when used with patients in the clinic once they’re marketed”, Hill added.

Hill went on to say: ”We are involved in several European projects which are collaborations with the pharmaceutical industry but also with major academic centres across Europe”’.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.